Drugs / Xuesaitong Soft Capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06425120 | Jun 2024 → Jun 2026 overdue | coronary artery disorder | China National Center for Cardiovascular Diseases | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xuesaitong Soft Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06425120 ↗ |